middle.news

How Did Aroa Biosurgery Achieve a 23% Revenue Surge and Profit in FY25?

1:26am on Monday 2nd of June, 2025 AEST Healthcare
Read Story

How Did Aroa Biosurgery Achieve a 23% Revenue Surge and Profit in FY25?

1:26am on Monday 2nd of June, 2025 AEST
Key Points
  • FY25 revenue of NZ$84.7 million, exceeding guidance
  • Normalised EBITDA profit of NZ$4.2 million, reversing prior year loss
  • Strong product growth led by Myriad (38%) and OviTex (22%)
  • Positive operating cash flow in second half of FY25
Read Story
middle.

Tap to Read

Tap the card to read the full analysis
about Aroa Biosurgery (ASX:ARX)
OPEN ARTICLE